Investing Ideas
/
Brazilian Pharmaceuticals & Biotech Insider-Bought Value Plays

Brazilian Pharmaceuticals & Biotech Insider-Bought Value Plays

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

1 companies

Hypera

Market Cap: R$14.3b

Operates as a pharmaceutical company in Brazil.

HYPE3

R$22.66

-3.4%

-5.7%